Search

Your search keyword '"Mark I van Berge Henegouwen"' showing total 249 results

Search Constraints

Start Over You searched for: Author "Mark I van Berge Henegouwen" Remove constraint Author: "Mark I van Berge Henegouwen" Search Limiters Full Text Remove constraint Search Limiters: Full Text
249 results on '"Mark I van Berge Henegouwen"'

Search Results

1. Effect of goal-directed therapy on outcome after esophageal surgery: A quality improvement study.

2. The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma

3. 18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making.

4. Surgeon Preference and Clinical Outcome of 3D Vision Compared to 2D Vision in Laparoscopic Surgery: Systematic Review and Meta-Analysis of Randomized Trials

5. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations

6. Radiomics in Oesogastric Cancer: Staging and Prediction of Preoperative Treatment Response: A Narrative Review and the Results of Personal Experience

7. Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition

8. Impact of malnutrition on early outcomes after cancer surgery: an international, multicentre, prospective cohort study

9. Vacuum-stent: A combination of endoscopic vacuum therapy and an intraluminal stent for treatment of esophageal transmural defects

10. Extended mobility scale (AMEXO) for assessing mobilization and setting goals after gastrointestinal and oncological surgery: a before-after study

11. Risk Factors, Diagnosis and Management of Chyle Leak Following Esophagectomy for Cancers

12. Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey

13. Investigating and Compensating for Periphery-Center Effect among Commercial Near Infrared Imaging Systems Using an Indocyanine Green Phantom

14. A population-based study in resected esophageal or gastroesophageal junction cancer aligned with CheckMate 577

15. Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer

16. Hospital Variation in Feeding Jejunostomy Policy for Minimally Invasive Esophagectomy: A Nationwide Cohort Study

17. Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies

18. Trends in Distal Esophageal and Gastroesophageal Junction Cancer Care

19. Preoperative Risk Stratification in Esophageal Cancer Surgery:Comparing Risk Models with the Clinical Judgment of the Surgeon

20. Effects of hospital facilities on patient outcomes after cancer surgery

21. Influence of postoperative complications following esophagectomy for cancer on quality of life: A European multicenter study

22. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

23. Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives

24. Improved Clinical and Survival Outcomes After Esophagectomy for Cancer Over 25 Years

25. The use of fluorescence angiography to assess bowel viability in the acute setting

26. The effect of anastomotic leakage on the incidence of recurrence after tri‐modality therapy for esophageal adenocarcinomas

27. Recurrent Disease After Esophageal Cancer Surgery

28. The effect of preoperative body mass index on short-term outcome after esophagectomy for cancer: A nationwide propensity score–matched analysis

29. C-Reactive Protein as a Negative Predictive Marker for Anastomotic Leakage After Minimally Invasive Esophageal Surgery

30. Figure from Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

31. Data from Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

32. Supplementary Data from Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

33. The impact of paratracheal lymphadenectomy on lymph node yield and short-term outcomes in esophagectomy for cancer: a nation-wide propensity score matched analysis

34. A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX

35. Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials

36. Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses

37. Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study

38. An International Multicenter Study Exploring Whether Surveillance After Esophageal Cancer Surgery Impacts Oncological and Quality of Life Outcomes (ENSURE)

39. Association between Surgical Patient Selection and Hospital Variation in Failure to Cure in Esophageal Cancer Surgery: A Nationwide Cohort Study

40. Clinical implications of chyle leakage following esophagectomy

41. Author response to

42. Identifying a core symptom set triggering radiological and endoscopic investigations for suspected recurrent esophago-gastric cancer : a modified Delphi consensus process

43. Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

44. Hospital Variation in Feeding Jejunostomy Policy for Minimally Invasive Esophagectomy

45. Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer

46. Treating Early Delayed Gastric Tube Emptying after Esophagectomy with Pneumatic Pyloric Dilation

47. Outcomes of Patients with Anastomotic Leakage After Transhiatal, McKeown or Ivor Lewis Esophagectomy: A Nationwide Cohort Study

48. Improved anastomotic leakage rates after the 'flap and wrap' reconstruction in Ivor Lewis esophagectomy for cancer

49. Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer

50. Evaluation of inter-user variability in indocyanine green fluorescence angiography to assess gastric conduit perfusion in esophageal cancer surgery

Catalog

Books, media, physical & digital resources